The most award winning
healthcare information source.
TRUSTED FOR FOUR DECADES.
This webinar begins with a summary of conventional prenatal screening. The webinar will review traditional test performance, discuss the consistent 5% false positive rate, and summarize the technology behind non-invasive prenatal testing (NIPT). Because NIPT has superior performance characteristics as a screening test for the common aneuploidies, adoption of this technology was rapid and led to the practice guideline statements of ACOG, SMFM, ACMG, and ISPD to help practitioners understand and implement this complex technology. Recent guidelines stated NIPT should be offered to high-risk women due to limited validation data in the average-risk population. However, there now is a large validation study recently published in the New England Journal of Medicine that proves NIPT out-performs conventional screening.
There are different ways to implement NIPT into general practice. Depending on the availability of a nuchal translucency ultrasound, some offices may do a viability scan and draw NIPT as early as 10 weeks. There are different protocols that can be implemented, but the most crucial part of implementation is patient education.
Making sure patients are properly informed and understand what NIPT is screening for is the crux of properly implementing this type of testing into practice, especially in the average pregnancy population.
Review the detailed agenda below and reserve your team a space today!
Call us at 800-688-2421 or add this event to your cart above and checkout online.
After this webinar, participants will be able to:
CEOs, COOs, CMOs, CE Directors, Department Directors, Quality Improvement Staff, Safety Officers and Staff, Ethics Committee Members, Consumer Advocates, Risk Managers, Legal Counsel, Social Workers, Physicians, Nurses (all levels), OB/GYNs, Midwives, MFMs.
Dr. Jay Steven Cohen MD, FACOG. is a board certified OB/GYN and has been in practice in the Plantation and Fort Lauderdale area for the past 24 years. He is currently the Medical Director for Sheridan Clinical Research and Discovery Clinical Research.
Dr. Cohen received his M.D. from USH/ Chicago Medical School and completed his residency at the University of Miami, Jackson Memorial Hospital.
Dr. Cohen has published in various scientific journals, including American Journal of Obstetrics and Gynecology, Current Medical Research and Opinions and Southern Medical Journal. In addition, Dr. Cohen maintains an extensive clinical practice and has served as a Board Member with the William Little OB/GYN Society, American Cancer Society (Breast Task Force), West Broward Unit of the American Cancer Society. And past member of The Board of Trustees at Plantation General Hospital. Dr. Cohen has been involved as a Principal Investigator of over 90 clinical trials on women's healthcare.